Clinical Trials Clinical Trials Kym Kilbourne 1734425431 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer More Clinical Trials Kym Kilbourne 1734426971 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Organoid-Based Functional Precision Treatment for Advanced Breast Cancer (ORIENTA) More Clinical Trials Kym Kilbourne 1734426963 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Ex Vivo Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer (ODYSSEY) More Clinical Trials Kym Kilbourne 1734426958 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Treatment of Drug-Resistant Relapsed Non-Small Cell Lung Cancer Guided by Patient-Derived Organoid Drug Sensitivity More Clinical Trials Kym Kilbourne 1734426949 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Ex Vivo Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumors More « 12 »
Clinical Trials Kym Kilbourne 1734425431 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer More
Clinical Trials Kym Kilbourne 1734426971 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Organoid-Based Functional Precision Treatment for Advanced Breast Cancer (ORIENTA) More
Clinical Trials Kym Kilbourne 1734426963 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Ex Vivo Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer (ODYSSEY) More
Clinical Trials Kym Kilbourne 1734426958 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Treatment of Drug-Resistant Relapsed Non-Small Cell Lung Cancer Guided by Patient-Derived Organoid Drug Sensitivity More
Clinical Trials Kym Kilbourne 1734426949 Dec 17,2024 Message from the President Kym Kilbourne Dec 17,2024 Ex Vivo Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumors More
